October 22, 2025

FDA Redefining Depression Treatment with New Approvals?

Researchers analyze FDA-approved and Phase 3 antidepressants from 2009 to 2025.

Conexiant

October 20, 2025

Tiny Chip, Big Breakthrough: Device Restores Reading Vision to Blind Eyes

AI-powered eye implant restores functional vision to people who had lost all sight

The Ophthalmologist

October 17, 2025

FDA Awards Nine CNPV Vouchers to Speed Reviews

Pilot aims to expedite access to high‑impact therapies by streamlining FDA review and strengthening sponsor–agency collaboration.

Conexiant

October 17, 2025

Stem Cell Study Uncovers Glial Cells That Accelerate Progressive MS 

Using a “disease-in-a-dish” model, researchers uncover glial cells that fuel chronic inflammation and neurodegeneration in progressive multiple sclerosis

The Analytical Scientist

October 16, 2025

HHS Memo: Fringe Finds a Footing

From wheat fields to Washington: a decades-old fear about skies and 'sprays' rises again, colliding with science, social media, and the machinery of federal policymaking.

KFF Health News

October 13, 2025

Blood Test Classified ME/CFS With 96% Accuracy, Study Shows

Epigenetic blood markers reveal immune activity patterns in patients with ME/CFS.

Conexiant

October 09, 2025

Is Science Retracting Enough Papers?

As paper mills and fraud proliferate, experts warn the retraction rate should reach 2% of published literature—ten times current levels.

Conexiant

October 08, 2025

Mass Spec Roundup: Iridoids, Isoforms, and Carbon Currents

Plus more mass spec stories…

The Analytical Scientist

October 08, 2025

AI Without Borders

An international coalition aims to tackle health inequities with a globally representative retinal AI model

The Ophthalmologist